Home » Topics » BioWorld Science

BioWorld Science
RSS

DexTech expands preclinical program to evaluate OsteoDex in multiple myeloma

Feb. 3, 2021

Curis initiates phase II LUCAS study of CA-4948 as treatment for anemia in MDS

Feb. 3, 2021

Phase I data presented for AXL inhibitor DS-1205c plus osimertinib in EGFR-mutated NSCLC

Feb. 3, 2021

BioCardia announces pipeline updates and milestones

Feb. 3, 2021

University of Southern California and collaborators patent opioid receptor agonists

Feb. 3, 2021

Cassava Sciences presents interim analysis data for simufilam in patients with Alzheimer's disease

Feb. 3, 2021

Annamycin shows significant therapeutic benefit in metastatic osteosarcoma animal model

Feb. 3, 2021

CSL Behring initiates Australian study of CSL-760 to treat serious cases of COVID-19

Feb. 3, 2021

FDA approves Posimir for post-surgical pain following arthroscopic subacromial decompression

Feb. 3, 2021

Kira initiates first-in-human study of P-014 for complement-mediated diseases

Feb. 3, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...